Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2012 by University of Zurich
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01429883
First received: September 5, 2011
Last updated: September 7, 2012
Last verified: September 2012
  Purpose

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.


Condition Phase
Fasciitis, Plantar
Achillodynia
Periarthritis Calcarea
Epikondylopathia Humeri /Radii
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 100
Study Start Date: July 2011
Estimated Study Completion Date: December 2013
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii, who got the shock wave therapy.

Criteria

Inclusion criteria:

-Patients with:

  • Fascititis plantaris,
  • Achillodynie,
  • Periarthropathia humerosacpularis calcarea or
  • Epicondylopathia humeri /radii, who got the shock wave therapy.

Exclusion criteria:

  • Anticoagulation,
  • Sepsis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01429883

Contacts
Contact: sandra Blumhardt, MD sandra.blumhardt@usz.ch

Locations
Switzerland
University Hospital Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
Principal Investigator: Sandra Blumhardt, MD University Hospital Zurich, Division of Rheumatology
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01429883     History of Changes
Other Study ID Numbers: ESWTRUZ01
Study First Received: September 5, 2011
Last Updated: September 7, 2012
Health Authority: Switzerland: UZurich

Additional relevant MeSH terms:
Fasciitis
Periarthritis
Fasciitis, Plantar
Musculoskeletal Diseases
Arthritis
Joint Diseases
Bursitis
Foot Diseases

ClinicalTrials.gov processed this record on August 28, 2014